335 related articles for article (PubMed ID: 9113450)
1. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
3. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
6. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
[TBL] [Abstract][Full Text] [Related]
7. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
Nwakanma LU; Williams JA; Weiss ES; Russell SD; Baumgartner WA; Conte JV
Ann Thorac Surg; 2007 Nov; 84(5):1556-62; discussion 1562-3. PubMed ID: 17954062
[TBL] [Abstract][Full Text] [Related]
8. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. The effect of peak and current serum panel-reactive antibody on graft survival.
Premasathian N; Panorchan K; Vongwiwatana A; Pornpong C; Agadmeck S; Vejbaesya S
Transplant Proc; 2008 Sep; 40(7):2200-1. PubMed ID: 18790191
[TBL] [Abstract][Full Text] [Related]
11. Sensitization.
Ogura K
Clin Transpl; 1992; ():357-69. PubMed ID: 1306712
[TBL] [Abstract][Full Text] [Related]
12. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
[TBL] [Abstract][Full Text] [Related]
13. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.
Opelz G;
Lancet; 2005 Apr 30-May 6; 365(9470):1570-6. PubMed ID: 15866311
[TBL] [Abstract][Full Text] [Related]
14. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?
Kobashigawa JA; Sabad A; Drinkwater D; Cogert GA; Moriguchi JD; Kawata N; Hamilton MA; Hage A; Terasaki P; Laks H
Circulation; 1996 Nov; 94(9 Suppl):II294-7. PubMed ID: 8901763
[TBL] [Abstract][Full Text] [Related]
16. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
18. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.
Lavee J; Kormos RL; Duquesnoy RJ; Zerbe TR; Armitage JM; Vanek M; Hardesty RL; Griffith BP
J Heart Lung Transplant; 1991; 10(6):921-9; discussion 929-30. PubMed ID: 1756157
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G-positive in B-cell cross-match decreases kidney allograft survival.
Fagundes I; Michelon T; Schoroeder R; Fernandes S; Sporleder H; Canabarro R; Rodrigues H; Petry M; Zanenga D; Silveira J; Montagner J; Bortolotto A; Keitel E; Santos A; Garcia V; Neumann J
Transplant Proc; 2005; 37(6):2753-4. PubMed ID: 16182801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]